A Post hoc analysis on rhythm and high intensity interval training in cardiac resynchronization therapy.
Xavier MeloAna AbreuVanessa SantosPedro CunhaMário OliveiraRita PintoMiguel CarmoBo FernhallHelena Santa-ClaraPublished in: Scandinavian cardiovascular journal : SCJ (2019)
Objectives. Evaluate the effects of a 6-month High Intensity Interval Training (HIIT) program on (1) functional capacity and health-related quality of life, (2) multiple blood biomarkers, (3) echocardiographic parameters, and (4) exercise performance, in patients in cardiac resynchronization therapy (CRT) stratified by the presence of atrial fibrillation (AF), targeting the following questions: (1) Does CRT provide similar benefits in patients in AF and sinus rhythm (SR)?; and (2) Does HIIT provides similar benefits in patients in AF and SR? Design. Estimates were available at baseline and 6 months after CRT implantation in 37 patients with heart failure. Patients were randomized after CRT to a 24-week HIIT group or to a usual care group (CON). In this sub-analysis, HIIT (AF = 7; SR = 11) and CON (AF = 9; SR = 10) were stratified by the presence of AF. Results. Patients in AF benefitted to a lesser degree from CRT in functional status than patients in SR (23.8-46.0%). However, HIIT induced superior improvements in patients in AF compared to CON (23.9-61.0%). Decreases in TNF-α (8.5-42.9%), BNP (15.3-34.6%) and left ventricular mass (9.6-26.2%) were only observed in patients in SR, whereas increases in peak oxygen uptake were only observed in patients in AF (19.5-23.2%). HIIT improved exercise capacity (8.8-59.4%) in patients in SR. Conclusions. Patients in AF or SR undergoing CRT demonstrated distinct benefits from device implantation and from HIIT as an adjunctive therapeutic strategy. This suggests that both mainstay and adjunctive therapeutics may need to be managed differently in patients in AF and SR.
Keyphrases
- end stage renal disease
- atrial fibrillation
- ejection fraction
- newly diagnosed
- left ventricular
- chronic kidney disease
- prognostic factors
- cardiac resynchronization therapy
- heart failure
- healthcare
- clinical trial
- patient reported outcomes
- randomized controlled trial
- oxidative stress
- drug delivery
- venous thromboembolism
- body composition
- transcatheter aortic valve replacement
- aortic stenosis
- placebo controlled
- high glucose
- double blind